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A B S T R A C T   
African Swine Fever (ASF) is a transboundary animal disease of pigs and wild suids that appeared in Lao People’s 
Democratic Republic (Lao PDR) in mid-2019, having spread across China and Vietnam in the months prior. 
Despite the scale of the Asian ASF pandemic and the availability of pen-side rapid diagnostic tests (RDT) on the 
market, few locally produced and easily available ASF RDTs have been evaluated for diagnostic accuracy. In this 
study, an ASF antigen detection RDT from Shenzhen Lvshiyuan Biotechnology Co. Ltd was evaluated using 
clinical field samples submitted to the National Animal Health Laboratory (NAHL) from ASF suspect cases be-
tween June and December 2019 in Lao PDR. Positive (n  57) and negative (n  50) samples of whole blood, 
serum and haemolysed serum were assessed by RDT and PCR, with the latter used as the gold standard reference 
comparator. Overall the RDT had a diagnostic sensitivity (DSe) of 65 %, 95 % CI [51–77] and diagnostic 
specificity (DSp) of 76 %, 95 % CI [62–87]. The RDT demonstrated improved performance on samples with lower 
PCR cycle threshold (ct) values with each additional cycle reducing the odds of the RDT returning a positive by 
17 % relative to the previous cycle, 95 % CI [8 %–28 %] (P < 0.01). While this test shows promise for field 
application, complete validation of diagnostic accuracy requires a larger sample size.   
African Swine Fever (ASF) is a DNA virus in the family Asfarviridae, 
genus Asfivirus. ASF is a viral transboundary animal disease affecting 
suids, easily transmitted by fomites and carried by soft ticks as a vector 
in east African and Iberian contexts (Sanchez-Vizcaíno et al., 2019). The 
ability of Southeast Asian soft ticks to carry ASF as a vector is as yet 
unstudied. ASF is moderately contagious but has up to 100 % mortality 
rates in affected herds (Sanchez-Vizcaíno et al., 2019). The virus can 
survive in the environment for extended periods and is present in all 
tissues and secretions of infected animals (Davies et al., 2017). Lao 
People’s Democratic Republic (Lao PDR) recorded its first outbreak of 
ASF in June 2019 (FAO, 2020) where pig farms experienced peracute 
and acute syndromes during this outbreak. Due to the dynamic nature of 
pig movements in southeast Asia (Leslie et al., 2015; Poolkhet et al., 
2019), ASF necessitates effective outbreak control before farmers rush to 
sell their symptomatic and at-risk pigs at a lower price rather than face 
losing the asset entirely (Dione et al., 2016). 
Broadly, ASF diagnostic assays fall into three categories: viral nucleic 
acid detection, antigen detection and antibody detection 
(Sanchez-Vizcaíno and Mur, 2013). The Lao Ministry of Agriculture and 
Forestry coordinates ASF diagnosis between sample collection at the 
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field level and centralised testing at the National Animal Health Labo-
ratory (NAHL) in Vientiane. The NAHL use real-time PCR (King et al., 
2003) for the reference diagnosis of ASF. However, the use of PCR as a 
sole diagnostic puts considerable strain on resources at the laboratory 
and delays field-based investigations and disease control activities 
during an active outbreak. Furthermore, Laos lacks a formal sample 
submission system and relies on public buses to transport test samples at 
ambient temperatures which may affect sample quality and cause delays 
in diagnosis. Rapid diagnostic tests (RDT) have been developed for the 
diagnosis of ASF detection of viral antigen. A European test strip 
(INgezim ASF CROM Ag from Eurofins Technologies Ingenasa1) per-
formed with diagnostic sensitivity (DSe) of 67.86 % and diagnostic 
specificity (DSp) of 97.98 % and is the only lateral flow assay to be 
evaluated at the time of publication (Sastre et al., 2016). Bionote Inc.2 
recently brought the Anigen Rapid ASFV Ag rapid test to market which 
shows good agreement with the reference PCR, however full validation 
data is not yet available (M. Thacker, pers comm, 2020). Additionally, a 
number of similar format tests are being produced in China, but these 
are yet to be evaluated for diagnostic accuracy. 
Measures of diagnostic accuracy like DSe and DSp allow operators to 
define a test’s ability to distinguish between a healthy animal and one 
that is affected by a disease of interest. In this study, we estimate the DSe 
and DSp of the Chinese-manufactured Shenzhen Lvshiyuan Biotech-
nology3 (SLB) ASF antigen detection RDT, which uses the colloidal gold 
immunochromatographic method. When a sample is placed in the 
testing well of the RDT, the virus will bind to colloidal gold labelled ASF 
antibody which will then move along the chromatographic membrane 
onto the test line where capture antibodies will show a wine-red line on 
the test cartridge (B. Zou, pers comm, 2020). A validated, accurate and 
affordable RDT for the confirmation of ASF could reduce the burden of 
testing on the laboratory during active outbreaks and provide faster 
decision-making tools for field staff. 
The pilot nature of the study determined the sample size. The DSe 
and DSp of the SLB ASF RDTs are stated to be 66.7 % and 100.0 %, 
respectively (L. Jiangcheng, pers comm, 2019). This study used 107 
samples from suspected-ASF cases from 16 provinces collected during 
the 2019 Lao outbreak, of which 57 were ASF positive, and 50 were ASF 
negative as determined by the reference ASF virus PCR using the the 
AgPath Mastermix and TaqMan PCR Assay (King et al., 2003). The 
negative samples were randomly chosen from a sampling frame 
extracted from the NAHL Pathogen Asset Control System (PACS) data-
base using RStudio (RStudioTeam, 2018). The positive samples used in 
the study represented all available ASF-positive samples with recorded 
cycle threshold values (ct values  number of PCR cycles required to 
detect viral DNA) ranging from 16  38. At the time of testing the SLB 
RDT recommended using fresh, refrigerated whole blood stored in 
EDTA. Due to this study occurring after the peak of the Lao pandemic, 
that was not possible. The samples utilised in this study were whole 
blood (n  58), hemolyzed serum (n  36) and non- hemolyzed serum 
(n  13). All test samples were stored at   80 C prior to testing. 
The SLB ASF RDT’s were performed according to the manufacturer’s 
instructions which are included in the appendices. The samples were 
thawed to room temperature before use in the RDT. All thawing and 
testing procedures were performed in a certificated class II biosafety 
cabinet. Two trained laboratory operators, blinded to the sample ASF 
test status, performed all testing. Briefly, four drops of each sample were 
mixed with a proprietary buffer in a microtube, followed by mixing 
within a transfer pipette eight times, before four drops of the solution 
were placed in the test well of the SLB ASF RDT cassette. The results 
were visually read at 20 min. The results of testing were stored in the 
PACS system and Microsoft Excel (Microsoft Corporation, USA). Raw 
sample results were exported to RStudio for analysis and the epi.tools() 
function from the epiR package was used to calculate diagnostic accu-
racy results and RDT characteristics (RStudioTeam, 2018; Stevenson 
et al., 2019). The 95 % confidence intervals for DSe and DSp were 
calculated using exact binomial methods. The effects of RDT result ~ ct 
value and RDT result ~ ct value  sample type were measured using 
binomial logistic regression after ct value was tested for linearity, using 
the glm() function in RStudio (RStudioTeam, 2018). 
Examples of positive and negative RDT results using whole blood, 
haemolysed serum and non-haemolysed serum are presented in Fig. 1. 
Generally, the whole blood sample RDT results were more difficult to 
interpret those of serum samples due to the darkening of the test strip; 
however, the positive and control lines were still discernible for all 
sample types. The overall SLB ASF RDT accuracy of results when 
combining all sample types was DSe 65 %, 95 % CI [51–77] and DSp 76 
%, 95 % CI [62–87] with the positive predictive value (PPV) 76 %, and 
the negative predictive value (NPV) 66 % (Table 1). The PCR ct value 
had a significant effect on the result for the RDT (p < 0.01) where each 
whole-number increase of a sample ct value, decreased the odds of the 
RDT returning a positive result by 17 %, 95 % CI [8 %–28 %]. Meaning a 
sample with a ct value of 17 had an almost 100 % probability of 
returning a positive value. In contrast, a sample with a ct value of 27.5 
had a probability closer to 50 % of returning a positive RDT result 
(Fig. 2). The effect of ct value on RDT result did not vary significantly by 
sample type. 
This study has some limitations due to the constraints and practi-
calities of sample testing during the 2019 ASF outbreak. Only ASF-PCR 
positive samples with ct values and sufficient volume could be selected 
for this evaluation. At the height of the epidemic, the PACS system was 
being used to catalogue sample status. However, the sample ct values 
were not recorded in PACS until later in the year. This led to a limited 
number of positive samples with ct values being available for diagnostic 
evaluation in this study. Based on the RDT characteristics estimated 
here, the sample size used in future studies to provide 95 % confidence 
with a 5% margin of error should be 350 ASF-positive and 280 ASF- 
negative samples. The current sample size produces a 12.5 % margin 
of error, as reflected in the 95 % CI. The use of late epidemic samples 
may have introduced potential bias into the ASF-positive sample selec-
tion and reduced the number of samples available. ASF-negative sam-
ples were randomly selected from the all available PCR negative samples 
archived during the pandemic, which may not be representative of non- 
ASF diseases causing similar symptoms. Finally, data were not submitted 
by field veterinarians regarding symptoms or stage of the disease of each 
sample. This information would have provided useful information to 
add to the analysis, as consistent clinical signs amongst positive tests 
Fig. 1. The appearance of different positive and negative sample types using 
the SLB ASF RDT. 
1 Av. de la Institucion Libre de Ense~nanza, 39 28037 Madrid, Spain.  
2 Bionote Inc., 22, Samseong 1-ro 4-gil, Dongtan 1-dong, Hwaseong-si, 
Gyeonggi-do, Republic of Korea  
3 Shenzhen Lvshiyuan Biotechnology Co., Ltd D Building, National Biological 
Industrial Park of Marinelife, No.2 Binhai Road, Dapeng, Shenzhen, 518120, 
China. 
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could provide a clinical syndrome to target in field testing. Future 
studies should aim to give helpful information to field veterinarians, 
such as ideal clinical presentation of animals to select for testing during 
an epidemic outbreak situation. 
Whilst the sample test kit instructed the use of refrigerated or fresh 
whole blood treated with EDTA, the samples used in the study were 
frozen and thawed, and the use of EDTA was unrecorded. Freezing 
whole blood induces a level of haemolysis that cannot be avoided, and 
may have affected the test performance. However, the test kit in-
structions included a step where the sample was to be drawn up and 
blown out of the provided pipette, presumably to induce haemolysis in 
the sample. Therefore, the test kit may perform differently using fresher 
samples, and in future studies investigators should endeavour to utilise 
the SLB RDT in active outbreak situations to better determine test 
characteristics on fresh whole blood. Based on the initial test charac-
teristics, it would be advisable to continue to only test anticoagulant 
treated whole blood samples from suspected sick or dead pigs. Focusing 
upon whole blood does not affect pen-side performance, as whole blood 
is more accessible than serum in the field. 
This study demonstrates the proof of concept for the use of a low-cost 
RDT in the field for ASF detection in an epidemic setting where re-
sources may be limited. The results presented here, while limited by 
pilot sample sizes, suggest that this test may have an application as a 
herd test in epidemic conditions where clinical ASF is suspected. Despite 
the wide confidence intervals, the results using whole blood resemble 
those of the similar European-produced Ingenasa test (Sastre et al., 
2016). Further validation of this test with a larger sample size could 
provide low- and middle-income governments with a greater diversity of 
choice in the diagnostic market. Future studies would benefit from 
presenting average cost differentials between the major diagnostic cat-
egories; however, this is not within the scope of this study. We recom-
mend that additional studies are formed to continue to define the 
diagnostic characteristics and applications of the SLB ASF RDT and other 
ASF detection rapid diagnostics that would lay the foundations to save 
valuable human and diagnostic resources during future ASF outbreaks. 
CRediT authorship contribution statement 
Nina Matsumoto: Writing - original draft, Investigation, Validation, 
Conceptualization. Jarunee Siengsanan-Lamont: Project administra-
tion, Writing - review & editing, Conceptualization. Laurence J. Glee-
son: Supervision, Writing - review & editing, Conceptualization. 
Bounlom Douangngeun: Project administration, Investigation. Wat-
thana Theppangna: Investigation, Validation. Syseng Khounsy: Proj-
ect administration, Investigation. Phouvong Phommachanh: 
Investigation, Validation. Tariq Halasa: Methodology, Formal analysis. 
Russell D. Bush: Supervision, Writing - review & editing. Stuart D. 
Blacksell: Supervision, Funding acquisition, Project administration, 
Writing - review & editing, Conceptualization. 
Declaration of Competing Interest 
All authors declare that they do not have a conflict of interest. 
Acknowledgements 
The authors are grateful for the efforts of field staff at the Lao 
Department of Livestock and Fisheries and the laboratory staff at the 
National Animal Health Laboratory, especially Khamphok Phithacthep. 
Stuart D. Blacksell is supported by the Wellcome Trust of the United 
Kingdom. This study was partially funded by the Defence Threat 
Reduction Agency, Biological Threat Reduction Program, of the US 
government [contract number HDTRA1-08-D-0007]. The authors 
acknowledge the statistical assistance Dr Kathrin Schemann of the 
Sydney Informatics Hub, a Core Research Facility of the University of 
Sydney. The authors would also like to thank Assoc Prof Jenny-Ann 
Toribio and Emeritus Prof Peter A. Windsor for their mentorship and 
advice leading up to and in the development of this study. 
References 
Davies, K., Goatley, L.C., Guinat, C., Netherton, C.L., Gubbins, S., Dixon, L.K., Reis, A.L., 
2017. Survival of african swine fever virus in excretions from pigs experimentally 
infected with the Georgia 2007/1 isolate. Transbound. Emerg. Dis. 64, 425–431. 
https://doi.org/10.1111/tbed.12381. 
Dione, M., Ouma, E., Opio, F., Kawuma, B., Pezo, D., 2016. Qualitative analysis of the 
risks and practices associated with the spread of African swine fever within the 
smallholder pig value chains in Uganda. Prev. Vet. Med. 135, 102–112. 
FAO, 2020. FAO ASF Situation Update - African Swine Fever (ASF) - FAO Emergency 
Prevention System for Animal Health (EMPRES-AH) [WWW Document]. URL http 
://www.fao.org/ag/againfo/programmes/en/empres/ASF/situation_update.html 
(accessed 2.5.20). 
King, D.P., Reid, S.M., Hutchings, G.H., Grierson, S.S., Wilkinson, P.J., Dixon, L.K., 
Bastos, A.D.S., Drew, T.W., 2003. Development of a TaqMan® PCR assay with 
internal amplification control for the detection of African Swine Fever virus. J. Virol. 
Methods 107, 53–61. https://doi.org/10.1016/S0166-0934(02)00189-1. 
Leslie, E.E.C., Christley, R.M., Geong, M., Ward, M.P., Toribio, J.A.L.M.L., 2015. Analysis 
of pig movements across eastern Indonesia, 2009–2010. Prev. Vet. Med. 118, 
293–305. https://doi.org/10.1016/j.prevetmed.2014.12.002. 
Poolkhet, C., Kasemsuwan, S., Phiphakhavong, S., Phouangsouvanh, I., Vongxay, K., 
Shin, M.S., Kalpravidh, W., Hinrichs, J., 2019. Social network analysis for the 
assessment of pig, cattle and buffalo movement in Xayabouli. Lao PDR. PeerJ 6, 
e6177. https://doi.org/10.7717/peerj.6177. 
RStudioTeam, 2018. RStudio: Integrated Development for R. 
Sanchez-Vizcaíno, J.M., Mur, L., 2013. African swine fever diagnosis update. Dev. Biol. 
(Basel) 135, 159–165. https://doi.org/10.1159/000189240. 
Sanchez-Vizcaíno, J.M., Laddomada, A., Arias, M.L., 2019. African swine fever virus. Dis. 
Swine 443–452. 
Sastre, P., Gallardo, C., Monedero, A., Ruiz, T., Arias, M., Sanz, A., Rueda, P., 2016. 
Development of a novel lateral flow assay for detection of African swine fever in 
blood. BMC Vet. Res. 12, 1–8. https://doi.org/10.1186/s12917-016-0831-4. 
Stevenson, M., Heuer, C., Marshall, J., Sanchez, J., Thornton, R., Reiczigel, J., Robison- 
Cox, J., Sebastiani, P., Solymos, P., Yoshida, K., Jones, G., Pirikahu, S., Firestone, S., 
Kyle, R., And, J.P., Jay, M., Nunes, T., 2019. epiR: Tools for the Analysis of 
Epidemiological Data. 
Table 1 
Diagnostic characteristics of the SLB ASF RDT using all sample types, and the 
performance using specific sample types.  








All samples (n  107) 65 [51–77] 76 [62–87] 76 66 
Whole blood (n  57) 63 [44–80] 85 [66–96] 83 68 
Haemolysed serum 
(n  36) 
50 [23–77] 68 [45–86] 50 68 
Non-haemolysed serum 
(n  13) 
NA 83 [52–98] 91 NA  
1 Diagnostic sensitivity (DSe); 2 Diagnostic specificity (DSp); 3 Positive pre-
dictive value (PPV); 4 Negative predictive value (NPV). 
Fig. 2. The probability of returning a positive SLB ASF RDT result given the 
sample’s ct value. 
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